Welcome to CDC stacks | Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada - 37285 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada
Filetype[PDF-376.88 KB]


Details:
No Related Documents.
You May Also Like:
  1. Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseriagonorrhoeae Strain
    Personal Author:
    Lahra, Monica M.; Martin, Irene; Demczuk, Walter; Jennison, Amy V.; Lee, Ken-Ichi; Nakayama, Shu-Ichi; Lefebvre, Brigitte; Longtin, Jean; Ward, Alison; Mulvey, Michael R.; Wi, Teodora; Ohnishi, Makoto; Whiley, David;
    Published:
    Apr 2018
    Source:
    Emerg Infect Dis. 24(4):735-740.
    Description:
    Ceftriaxone remains a first-line treatment for patients infected by Neisseria gonorrhoeae in most settings. We investigated the possible spread of a ceftriaxone-resistant FC428 N. gonorrhoeae clone in Japan after recent isolation of similar strains i...
    File Type:
    Filetype[PDF - 703.13 KB]
  2. Neisseria gonorrhoeae antimicrobial susceptibility surveillance — the Gonococcal Isolate Surveillance Project, 27 sites, United States, 2014
    Personal Author:
    Kirkcaldy, Robert D.; Harvey, Alesia; Papp, John R.; Del Rio, Carlos; Soge, Olusegun O.; Holmes, King K.; Hook, Edward W.; Kubin, Grace; Riedel, Stefan; Zenilman, Jonathan M.; Pettus, Kevin; Sanders, Tremeka; Sharpe, Samera; Torrone, Elizabeth;
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention..
    Published:
    July 15, 2016
    Series:
    MMWR. Surveillance summaries : Morbidity and mortality weekly report. Surveillance summaries ; v. 65, no. SS-7
    Description:
    Problem/Condition: Gonorrhea is the second most commonly reported notifiable disease in the United States; 350,062 gonorrhea cases were reported in 2014. Sexually transmitted infections caused by Neisseria gonorrhoeae are a cause of pelvic inflammato...
    File Type:
    Filetype[PDF - 505.71 KB]
  3. Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action
    Personal Author:
    Wi, Teodora; Lahra, Monica M.; Ndowa, Francis; Bala, Manju; Dillon, Jo-Anne R.; Ramon-Pardo, Pilar; Eremin, Sergey R.; Bolan, Gail; Unemo, Magnus;
    Published:
    Jul 07 2017
    Source:
    PLoS Med. 2017; 14(7).
    Description:
    In a Policy Forum, Teodora Wi and colleagues discuss the challenges of antimicrobial resistance in gonococci.
    File Type:
    Filetype[PDF - 2.53 MB]
  4. Antimicrobial resistance expressed by Neisseria gonorrhoeae: a major global public health problem in the 21st century
    Personal Author:
    Unemo, Magnus; del Rio, Carlos; Shafer, William M.;
    Published:
    Jun 2016
    Source:
    Microbiol Spectr. 4(3).
    Description:
    Neisseria gonorrhoeae is a strictly human pathogen that is typically transmitted by sexual contact. The associated disease gonorrhea has plagued humankind for thousands of years, with a current estimated incidence of 78 million cases per year. Advanc...
    File Type:
    Filetype[PDF - 684.23 KB]
  5. Technological Solutions to Address Drug-Resistant Neisseria gonorrhoeae
    Personal Author:
    Bristow, Claire C.; Dong, Huan; Klausner, Jeffrey D.;
    Published:
    May 2016
    Source:
    Emerg Infect Dis. 22(5):939-940.
    File Type:
    Filetype[PDF - 273.41 KB]